Diffuse astrocytoma grading
Updates to Article Attributes
Grading of diffuse astrocytic tumours in adults has been done according to a number of systems over the years, although by far the most popular now being the WHO grading system.
Historically these grading systems focusedfocussed on the presence or absence of a number of histological features, although more recently genetic/molecular markers have been introduced into the grading schema 3,6:
Histological features historically used include:
- cellular atypia/anaplasia
- mitotic activity
- microvascular proliferation
- necrosis typically with perinecrotic palisading
Classification systems include:
- WHO grading system (most common)
- St.Anne-Mayo grading system
- Kernohan grading system
- Modified Ringertz grading system
Direct equivalence between the grades of various grading systems is of course not possible (otherwise they wouldn't be different systems), and thus care should be taken to state which system is being used and, in some situations, which edition; for example, the 5th edition (2021) WHO classification of CNS tumours suggests prefacing the grade by "WHO CNS" 4,6.
It should be noted that it is well recognised that pathological classification has a high interobserver variation and thus imperfectly predicts clinical outcomes 5.
-<p><strong>Grading of diffuse astrocytic tumours in adults</strong> has been done according to a number of systems over the years, although by far the most popular now being the <a href="/articles/who-grading-system-for-diffuse-astrocytomas">WHO grading system</a>.</p><p>Historically these grading systems focused on the presence or absence of a number of histological features, although more recently genetic/molecular markers have been introduced into the grading schema <sup>3,6</sup>:</p><p>Histological features historically used include:</p><ul>- +<p><strong>Grading of diffuse astrocytic tumours in adults</strong> has been done according to a number of systems over the years, although by far the most popular now being the <a href="/articles/who-grading-system-for-diffuse-astrocytomas">WHO grading system</a>.</p><p>Historically these grading systems focussed on the presence or absence of a number of histological features, although more recently genetic/molecular markers have been introduced into the grading schema <sup>3,6</sup>:</p><p>Histological features historically used include:</p><ul>
Tags changed:
- who cns 5
Image 4 MRI (FLAIR) ( create )
Image 5 MRI (T1 C+) ( create )
Unable to process the form. Check for errors and try again.